Skip to main navigation Skip to search Skip to main content

Depressive symptom trajectories in older breast cancer survivors: the Thinking and Living with Cancer Study

  • Zev M. Nakamura
  • , Brent J. Small
  • , Wanting Zhai
  • , Tim A. Ahles
  • , Jaeil Ahn
  • , Ashley L. Artese
  • , Traci N. Bethea
  • , Elizabeth C. Breen
  • , Harvey J. Cohen
  • , Martine Extermann
  • , Deena Graham
  • , Michael R. Irwin
  • , Claudine Isaacs
  • , Heather S.L. Jim
  • , Kate R. Kuhlman
  • , Brenna C. McDonald
  • , Sunita K. Patel
  • , Kelly E. Rentscher
  • , James C. Root
  • , Andrew J. Saykin
  • Danielle B. Tometich, Kathleen Van Dyk, Xingtao Zhou, Jeanne S. Mandelblatt, Judith E. Carroll
  • University of North Carolina at Chapel Hill
  • University of South Florida
  • Georgetown University
  • Memorial Sloan-Kettering Cancer Center
  • Duke University
  • University of California at Los Angeles
  • Moffitt Cancer Center
  • University of California at Irvine
  • Indiana University Bloomington
  • City of Hope National Med Center
  • Medical College of Wisconsin

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

Purpose: To identify trajectories of depressive symptoms in older breast cancer survivors and demographic, psychosocial, physical health, and cancer-related predictors of these trajectories. Methods: Recently diagnosed nonmetastatic breast cancer survivors (n = 272), ages 60–98 years, were evaluated for depressive symptoms (Center for Epidemiological Studies Depression Scale, CES-D; scores ≥16 suggestive of clinically significant depressive symptoms). CES-D scores were analyzed in growth-mixture models to determine depression trajectories from baseline (post-surgery, pre-systemic therapy) through 3-year annual follow-up. Multivariable, multinomial logistic regression was used to identify baseline predictors of depression trajectories. Results: Survivors had three distinct trajectories: stable (84.6%), emerging depressive symptoms (10.3%), and recovery from high depressive symptoms at baseline that improved slowly over time (5.1%). Compared to stable survivors, those in the emerging (OR = 1.16; 95% CI = 1.08–1.23) or recovery (OR = 1.26; 95% CI = 1.15–1.38) groups reported greater baseline anxiety. Greater baseline deficit accumulation (frailty composite measure) was associated with emerging depressive symptoms (OR = 3.71; 95% CI = 1.90–7.26). Less social support at baseline (OR = 0.38; 95% CI = 0.15–0.99), but greater improvement in emotional (F = 4.13; p = 0.0006) and tangible (F = 2.86; p = 0.01) social support over time, was associated with recovery from depressive symptoms. Conclusions: Fifteen percent of older breast cancer survivors experienced emerging or recovery depressive symptom trajectories. Baseline anxiety, deficit accumulation, and lower social support were associated with worse outcomes. Implications for Cancer Survivors: Our results emphasize the importance of depression screening throughout the course of cancer care to facilitate early intervention. Factors associated with depressive symptoms, including lower levels of social support proximal to diagnosis, could serve as intervention levers.

Original languageEnglish
Pages (from-to)568-579
Number of pages12
JournalJournal of Cancer Survivorship
Volume19
Issue number2
DOIs
StatePublished - Apr 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Breast cancer
  • Cancer survivorship
  • Depression
  • Frailty
  • Older adults
  • Social support

Fingerprint

Dive into the research topics of 'Depressive symptom trajectories in older breast cancer survivors: the Thinking and Living with Cancer Study'. Together they form a unique fingerprint.

Cite this